Pulmonary arterial hypertension market to generate sales of approximately $4.75 billion by the end of 2024

Pulmonary arterial hypertension market to generate sales of approximately $4.75 billion by the end of 2024 The Pulmonary Arterial Hypertension (PAH) therapeutics market will experience modest growth from $3.45 billion in 2014 to $4.75 billion by 2024, representing a Compound Annual Growth Rate (CAGR) of 3.2%.This report on the global pulmonary arterial hypertension (PAH) market offers an insightful and in-depth assessment of the current and future market potential of PAH drugs.

More information

Stroke Market Size, Causes, Outlook, Overview and Pipeline Review, H1 2016

Stroke Market Size, Causes, Outlook, Overview and Pipeline Review, H1 2016 Global Markets Direct's, 'Stroke - Pipeline Review, H1 2016', provides an overview of the Stroke pipeline landscape. Read more @ http://www.radiantinsights.com/research/stroke-pipeline-review-h1-2016

More information